| Karl Smart, | |
|
745 S Milledge Ave, Athens, GA 30605-1252 | |
| (706) 498-9560 | |
| Not Available |
| Full Name | Karl Smart |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 17 Years |
| Location | 745 S Milledge Ave, Athens, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124295332 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Athens Regional Medical Center | Athens, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Personal Recovery Network Llc | 5092611384 | 251 |
| Piedmont Athens Hospitalist Physicians Llc | 6305196411 | 105 |
News Archive
A 4-year-old girl was rushed to the emergency room three times in one week for asthma attacks.
Cobimetinib (trade name: Cotellic) has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received U.S. Food and Drug Administration approval for the Mitroflow Aortic Pericardial Heart Valve with PRT.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 1 days ago
| Entity Name | Piedmont Hospitalist Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548219660 PECOS PAC ID: 1951299163 Enrollment ID: O20040309000820 |
News Archive
A 4-year-old girl was rushed to the emergency room three times in one week for asthma attacks.
Cobimetinib (trade name: Cotellic) has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received U.S. Food and Drug Administration approval for the Mitroflow Aortic Pericardial Heart Valve with PRT.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 1 days ago
| Entity Name | Personal Recovery Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881990869 PECOS PAC ID: 5092611384 Enrollment ID: O20120110000096 |
News Archive
A 4-year-old girl was rushed to the emergency room three times in one week for asthma attacks.
Cobimetinib (trade name: Cotellic) has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received U.S. Food and Drug Administration approval for the Mitroflow Aortic Pericardial Heart Valve with PRT.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 1 days ago
| Entity Name | Piedmont Athens Hospitalist Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578079000 PECOS PAC ID: 6305196411 Enrollment ID: O20180911003967 |
News Archive
A 4-year-old girl was rushed to the emergency room three times in one week for asthma attacks.
Cobimetinib (trade name: Cotellic) has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received U.S. Food and Drug Administration approval for the Mitroflow Aortic Pericardial Heart Valve with PRT.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 1 days ago
| Entity Name | Piedmont Athens Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184130627 PECOS PAC ID: 8820349772 Enrollment ID: O20180917001273 |
News Archive
A 4-year-old girl was rushed to the emergency room three times in one week for asthma attacks.
Cobimetinib (trade name: Cotellic) has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received U.S. Food and Drug Administration approval for the Mitroflow Aortic Pericardial Heart Valve with PRT.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karl Smart, 411 Holman Ave, Athens, GA 30606-2666 Ph: () - | Karl Smart, 745 S Milledge Ave, Athens, GA 30605-1252 Ph: (706) 498-9560 |
News Archive
A 4-year-old girl was rushed to the emergency room three times in one week for asthma attacks.
Cobimetinib (trade name: Cotellic) has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received U.S. Food and Drug Administration approval for the Mitroflow Aortic Pericardial Heart Valve with PRT.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 1 days ago
Ms. Susan Gail Adams, APRN-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1905 Barnett Shoals Rd, Athens, GA 30605 Phone: 706-542-7053 | |
Ireta Favors, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 250 Bray St, Athens, GA 30601 Phone: 678-215-4907 Fax: 678-671-8489 | |
Melissa Bienacker Baughcum, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 340 N Milledge Ave Ste B, Athens, GA 30601 Phone: 706-548-0008 Fax: 706-369-9673 | |
Amanda Gunter, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1175 Mitchell Bridge Rd, Athens, GA 30606 Phone: 706-534-4637 | |
Lauren Gruendling, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 242 King Avenue, Suite 210, Athens, GA 30606 Phone: 706-475-1700 | |
Oyebisi Moriliat Kilani, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 770-910-9196 Fax: 770-910-9196 | |
Cheryl Y Reed, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2142 W Broad St Bldg 100 Ste 200, Athens, GA 30606 Phone: 706-548-6881 Fax: 706-546-0821 |